DHR Danaher Corporation logo

DHR Danaher Corporation

Healthcare
$172.00-0.77%ClosedMarket Cap: $121.74B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

37.10

PEG

P/B

2.30

P/S

4.91

EV/EBITDA

20.11

DCF Value

$219.45

FCF Yield

4.3%

Div Yield

0.8%

Margins & Returns

Gross Margin

60.7%

Operating Margin

21.0%

Net Margin

14.9%

ROE

7.1%

ROA

4.4%

ROIC

5.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$5.95B$1.03B$
Q4 null$6.84B$1.20B$
FY null$24.57B$3.61B$
Q3 null$6.05B$908.0M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$242.30

Target (Median)

$247.00

Target Range

$200.00 - $270.00

4 Strong Buy19 Buy2 Hold0 Sell0 Strong Sell
Morgan StanleyOverweight
2026-04-23
UBSBuy
2026-04-22
Wells FargoEqual Weight
2026-04-22
BairdOutperform
2026-04-22
GuggenheimBuy
2026-04-22

Trading Activity

Insider Trades

View All
Stevens Raymond Cdirector
SellTue May 19
Stevens Raymond Cdirector
SellTue May 19
SPOON ALAN Gdirector
SellTue May 19
SPOON ALAN Gdirector
SellTue May 19
Sanders A Shanedirector
SellTue May 19

Congress Trades

View All
Michael McCaulBuy
Mon May 11
Michael McCaulBuy
Fri Apr 10

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

0.84

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Peers